UNITED THERAPEUTICS CORP (UTHR) Institutional Ownership Changes & 13F Activity

UNITED THERAPEUTICS CORP (UTHR). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings. This page analyzes institutional buying and selling activity, new holdings, and sold-out positions among tracked filers. Notable filers include Renaissance Technologies LLC, Sequoia Financial Advisors, Mairs & Power Growth Fund, Hancock Classic Value, and First Eagle U.S. Value.

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q1 2026Renaissance Technologies LLCSell-122,2401,787,019$1,059,666,527
Q1 2026Sequoia Financial AdvisorsSell-8472,424$1,437,384
Q1 2026Mairs & Power Growth FundBuy350350$207,543
Q4 2025Renaissance Technologies LLCSell-264,1331,909,259$930,286,448
Q4 2025Sequoia Financial AdvisorsBuy1,4873,271$1,593,795
Q3 2025Renaissance Technologies LLCBuy54,3002,173,392$911,107,660
Q3 2025Sequoia Financial AdvisorsBuy7171,784$747,871
Q2 2025Renaissance Technologies LLCBuy12,1002,119,092$608,921,086
Q2 2025Sequoia Financial AdvisorsBuy4001,067$306,603
Q1 2025Renaissance Technologies LLCBuy17,6002,106,992$649,522,424
Q1 2025Sequoia Financial AdvisorsSell-186667$205,617
Q4 2024Renaissance Technologies LLCSell-66,0002,089,392$737,221,073
Q4 2024Sequoia Financial AdvisorsBuy130853$300,973
Q3 2024Renaissance Technologies LLCSell-19,3002,155,392$772,384,723
Q3 2024Sequoia Financial AdvisorsBuy81723$259,088
Q2 2024Renaissance Technologies LLCBuy22,9782,174,692$692,748,137
Q2 2024Sequoia Financial AdvisorsBuy642642$204,510
Q2 2024Hancock Classic ValueSell-4981,599$509,361
Q1 2024Renaissance Technologies LLCSell-18,5002,151,714$494,292
Q1 2024Hancock Classic ValueBuy752,097$481,723
Q4 2023Renaissance Technologies LLCSell-80,2942,170,214$477,208
Q4 2023Hancock Classic ValueBuy1592,022$444,618
Q3 2023Renaissance Technologies LLCBuy63,2942,250,508$508,322
Q3 2023Hancock Classic ValueSell-2111,863$420,796
Q2 2023Renaissance Technologies LLCSell-40,2002,187,214$482,827
Q2 2023Hancock Classic ValueBuy3692,074$457,836
Q1 2023Renaissance Technologies LLCSell-117,0782,227,414$498,852
Q1 2023Hancock Classic ValueSell-1,0631,705$381,852
Q4 2022Renaissance Technologies LLCSell-205,7222,344,492$651,980
Q3 2022Renaissance Technologies LLCSell-243,3772,550,214$533,964

Frequently asked questions about UTHR activity

  • Which institutional owners are buying UTHR?

    Institutional owners buying UTHR include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in UTHR activity?

    "Buy" means an investor increased their reported position in UTHR compared to the prior reporting period. This reflects growing exposure to UNITED THERAPEUTICS CORP (UTHR) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in UTHR increasing?

    Institutional interest in UTHR can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.

Related UTHR Institutional Insights